Clinical trial
A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia
NCT00160121 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Open-Label, Multi-Center Trial Evaluating the Efficacy of Fosrenol Compared to Existing Therapy in Adults With End Stage Renal Disease Treated for Hyperphosphatemia
- Lead sponsor
- Shire
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 10, 2005
- Completion date
- December 13, 2005
- Enrollment
- 2,500
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.